Link to Life Science Fireside Chat
Thursday, April 26
5:30 - 7:30 PM
From public to private, large to small sized business management April’s featured Link to Life Science Series speakers are responsible for leading international corporations, impacting human lives through their innovative work. Join Delaware Bio on Thursday, April 26 for a Link to Life Science Fireside Chat featuring Fran DiNuzzo, CEO, ILC Dover and Greg Tronto, Business Development Manager, W.L. Gore & Associates, and moderated by Kevin Cameron, CEO, Connect Delaware.
The Link to Life Science Series: Fireside Chat will be held at the Delaware Biotechnology Institute.
For questions or more information, contact Amana Coates at email@example.com
COST: MEMBERS $25 | IN-TRANSITION: $25 | NON-MEMBERS: $50
CEO ILC Dover
Fran DiNuzzo brings more than 35 years of management and manufacturing experience to his role as President and CEO of ILC Dover, one of the largest manufacturing companies in Delaware.
During his career, Fran has led a variety of public and private companies, from small, emerging firms to large corporations. He is adept at forging relationships with upper-level decision makers, solving business challenges and leading teams to achieve innovative results.
After holding high-level managerial positions at Hewlett-Packard, Agilent Technologies, Strategic Diagnostics and SDIX, Fran became President of ILC Dover in 2014.
He took the helm as President and CEO in 2015, leading the 600+ employee company in the design, engineering and manufacturing of innovative products for the pharma/biopharm, packaging, aerospace, flood protection, and safety industries.
Fran places a high priority on community service, serving on the board of directors of the Delaware BioScience Association, Delaware Business Roundtable and Junior Achievement of Delaware.
He holds bachelor’s and master’s degrees in Mechanical Engineering from the University of New Hampshire.
Business Development Manager
W.L. Gore & Associates
Throughout his 30+ year career, Greg Tronto has earned a reputation as an innovative new business builder. He has a proven track record of identifying and establishing market-driven product concepts and leading the early stage development of high-growth, long term sustainable products for Gore.
Greg joined W.L. Gore & Associates, Inc. in 1988, working in applications engineering and technical sales in the industrial filtration market. The majority of his career has been working in product development, building external collaborations and strategic alliances, and leading newly formed teams and businesses. He has extensive global experience, including European and Asian industrial market development. Greg has authored industry white papers and has been a presenter at leading industry trade events and forums.
Currently, he works as business development lead for Gore’s PharmBIO Products, which was established in 2009. His focus is to continue to build a portfolio of differentiated products by creating and shaping new product concepts which tie to Gore’s core technologies that aim to serve the pharmaceutical and biopharmaceutical markets. His primary focus is downstream bioprocess, packaging and drug delivery. Greg is currently managing the market interface for several large pharma co-development efforts which include stem cell therapy for diabetes and targeted drug delivery using controlled release materials. He currently serves on the board of the Delaware Bioscience Association.
Greg holds a BS in Mechanical Engineering, is married with two children and resides in Hockessin, Delaware. He enjoys sports, exercise, sports cars, auto restoration, travel, the beach, remodeling homes, a good craft beer (or two…) and spending time with family and close friends.
Delaware Biotechnology Institute, Innovation Way, Newark, DE, USA